Unigen has partnered with Europe based LEHVOSS Nutrition.
Through this mutual collaboration, three of Unigen’s patented, clinically proven ingredients have been added to the LEHVOSS Nutrition brands portfolio to be promoted in Europe: Univestin for fast acting joint support, Attenutin for respiratory health support and Anivestin for joint discomfort and oral health in companion animals.
“We are really excited for this new partnership with LEHVOSS Nutrition to bring Unigen’s three ingredients into the European market,” said Dr Qi Jia, President and CEO. “Unigen develops its proprietary, patented, and clinically proven ingredients through rigorous scientific research using our PhytoLogix Technology Platform, a database of comprehensive botanical profiles on over 12,000 plants and 15,000 extracts. This is synergistic with LEHVOSS Nutrition’s brands portfolio and philosophy.”
Teresita Rudà, Head of Brands and Marketing LEHVOSS Nutrition added: “We have followed Unigen’s developments and scientific research in the USA with great interest over the last six years, and we are very pleased that they see LEHVOSS as the right partner for distribution in Europe. Both technical teams have done some great teamwork, spending almost 12 months to ensure regulatory compliance on these ingredients. We have finally achieved the stage where these three selected brands are ready for launch in Europe, our sales team is fully engaged and key customers have already started to look into them with great excitement.”
LEHVOSS Nutrition specialises in scientifically proven, trademarked ingredients manufactured by top worldwide companies and distributed by LEHVOSS subsidiaries throughout Europe.
